ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 58

What Does the Patient Global Assessment Mean for Patients with Psoriatic Arthritis? A Post-Hoc Analysis of 223 Patients with Psoriatic Arthritis

Sandra Tälli1, Adrien Etcheto2, Bruno Fautrel3, Andra Balanescu4, Jürgen Braun4, Juan D. Cañete5, Kurt de Vlam4, Maarten de Wit4, Turid Heiberg4, Philip S. Helliwell4, Umut Kalyoncu4, Uta Kiltz6, Mara Maccarone4, Dora Niedermayer4, Kati Otsa4, Rossana Scrivo4, Josef Smolen4, Tanja Alexandra Stamm4, Douglas J. Veale7, Tore K. Kvien4 and Laure Gossec3, 1Rheumatology, GRC UPMC Paris 06 University, Pitie-Salpétriere hospital, Paris, France, 2Cochin Hospital, Paris Descartes University, Paris, France, 3Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, 4PsAID taskforce, EULAR, Zurich, Switzerland, 5Rheumatology, Hospital Clinic, Barcelona, Spain, 6Rheumazentrum Ruhrgebiet, Herne, Germany, 7Translational Rheumatology Research Group, St. Vincent's University Hospital, Dublin 4, Ireland

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Outcome measures, pain and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health: Osteoporosis, Non-Inflammatory Arthritis and More

Session Type: Abstract Submissions (ACR)

Background/Purpose

Patient global assessment (PGA) is one of the most widely used patient reported outcomes (PROs) in psoriatic arthritis (PsA). PGA should reflect the global impact of the disease from the patient’s perspective, however we lack information on the concepts encompassed in PGA. In addition the Group of Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has proposed to use also two specific (joints, skin) patient assessments but their scope is also unclear. (1) Recently the European League Against Rheumatism (EULAR) developed the PsAID (Psoriatic Arthritis Impact of the Disease) which includes 12 domains of health important for patients. (2)

Objective: to explore PGA in PsA from the patient’s point of view by comparing it to the PsAID domains of health and also to explore the two specific (joints, skin) patient assessments in relation to PGA.

Methods

Post-hoc analysis of the cross-sectional PsAID study (2) for patients with definite PsA (according to the Classification Criteria for Psoriatic Arthritis (CASPAR) criteria). Data collection included PGA (“Considering all the ways PsA has affected you during the last week, circle the number that best describes how you have been doing”), skin and joint patient assessments (patient global assessments of these 2 aspects) and PsAID questions covering physical (including joints and skin), psychological and social impact of PsA. The concepts covered by PGA were explored by univariate (Spearman correlation coefficient) and multivariate linear regression, and intra-class correlation between PGA and joint and skin patient assessments was calculated.

Results

Among 223 patients (mean age 51.0 (standard deviation, ±13.3) years, mean disease duration 9.9 (±10.1) years, mean swollen joint count 4.1 (±5.1), 84.3% with current psoriasis (mainly of less than 5% body surface area)), 51.1% were females. Mean patient assessment values were for PGA 4.8 (±2.7), joint patient assessment 5.6 (±2.5) and skin patient assessment 4.1 (±3.0). Multivariate linear regression indicated that PGA was well explained (R² of model 0.754) by coping (β= 0.287); pain (β= 0.240); work and/or leisure activities (β= 0.141); and anxiety (β= 0.109). Intra-class correlation between PGA and joint or skin patient assessment was respectively 0.71 [95% confidence interval, 0.64-0.77] and 0.52 [95% confidence interval, 0.42-0.60].

Conclusion

PGA in PsA is explained by coping, then as expected physical aspects of impact which may reflect joint involvement: pain and work/leisure activities; and psychological impact: anxiety. In this population, skin related issues were not additional explanatory elements of PGA in multivariate analysis. Finally, joint patient assessment may be redundant with PGA whereas skin patient assessment gives additional information in characterizing the disease and its impact.

References

1. Cauli et al. J Rheum 2011; 38:5.

2. Gossec et al. Ann Rheum Dis 2014;73:1012-1019.


Disclosure:

S. Tälli,
None;

A. Etcheto,
None;

B. Fautrel,
None;

A. Balanescu,
None;

J. Braun,

Abbott Immunology Pharmaceuticals,

5,

MSD,

5,

Pfizer Inc,

5,

UCB,

5;

J. D. Cañete,
None;

K. de Vlam,
None;

M. de Wit,
None;

T. Heiberg,
None;

P. S. Helliwell,
None;

U. Kalyoncu,
None;

U. Kiltz,
None;

M. Maccarone,
None;

D. Niedermayer,
None;

K. Otsa,
None;

R. Scrivo,
None;

J. Smolen,
None;

T. A. Stamm,
None;

D. J. Veale,
None;

T. K. Kvien,
None;

L. Gossec,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-does-the-patient-global-assessment-mean-for-patients-with-psoriatic-arthritis-a-post-hoc-analysis-of-223-patients-with-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology